Permanent Price Reductions
Author: APCI Staff/Thursday, May 12, 2022/Categories: Generics and Vendor Contracting, Pricing
McKesson announced the following permanent price reductions effective May 12, 2022:
| Item# |
Description |
Old Invoice |
New Invoice |
Delta $$ |
Delta % |
| 3575867 |
SUMATRIPTAN N/S 5MG.1ML LANN6@ |
$394.43 |
$285.00 |
$(109.43) |
-28% |
| 1545946 |
SODIUM SUF 9.8%/4.8% WEST10OZ@ |
$237.50 |
$142.49 |
$(95.00) |
-40% |
| 3558517 |
ETODOLAC ER TAB 400MG 60NSTR@ |
$130.90 |
$111.15 |
$(19.75) |
-15% |
| 3558525 |
ETODOLAC ER TAB 400MG 100NSTR@ |
$220.88 |
$185.25 |
$(35.63) |
-16% |
| 3756103 |
RASAGILINE MESY TB.5MG30NSTAR@ |
$148.38 |
$94.99 |
$(53.39) |
-36% |
| 1547181 |
MEMANT HCL ER CP 7MG ZYD 30@ |
$54.14 |
$42.74 |
$(11.40) |
-21% |
| 2335388 |
NICARDIPINE HCL CP 20MG ANI90@ |
$1,007.02 |
$855.02 |
$(152.00) |
-15% |
Tags: